Clinical observation of treatment in ovary endometriosis with Mifepriston and Gestrinone after laparoscopic surgery

Objective:To investigate the role of Mifepriston and Gestrinone in ovary endometriosis after Laparoscopic surgery.Methods:86 women with ovary endometriosis after Laparoscopic surgery were divided into three groups: group A-30 cases in Mifepriston 12.5 mg take orally;group B-30 cases in Gestrinone 2.5 mg take orally;group C-26 cases in Laparoscopic surgery only.All patients were visited 3 to 24 months and observed curative effect.Results: Rates of efficiency was 75.9% in group A.Rates of efficiency was 79.3% in group B.Rates of efficiency was 58.3% in group C.The3 curative effects of both group A and group B were similar significant higher than group C(P0.05).The side effects of Mifpriston were significant lower than Gestrinone's.Conclusion:Depot Mifepriston seems to be an effective,safe, and convenient treatment for ovary endometriosis with low-cost and few side effects.Then it can be used medication after surgery.